Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBP-201 in Adults With Moderate-to-Severe Atopic Dermatitis
CTR20200206Phase 2Completed
- Sponsor
- Connect Biopharma
- Start
- Nov 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of rademikibart in atopic dermatitis (AD), sponsored by Connect Biopharma. Started Nov 2020; status: completed.
02
Drugs
rademikibart
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20200206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200206.